NZ763905B2 - An embolisation device - Google Patents
An embolisation deviceInfo
- Publication number
- NZ763905B2 NZ763905B2 NZ763905A NZ76390515A NZ763905B2 NZ 763905 B2 NZ763905 B2 NZ 763905B2 NZ 763905 A NZ763905 A NZ 763905A NZ 76390515 A NZ76390515 A NZ 76390515A NZ 763905 B2 NZ763905 B2 NZ 763905B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- segment
- proximal
- stem
- distal
- membrane
- Prior art date
Links
- 239000012528 membrane Substances 0.000 claims abstract description 188
- 230000007246 mechanism Effects 0.000 claims abstract description 32
- 238000004873 anchoring Methods 0.000 claims abstract description 18
- 239000003550 marker Substances 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 21
- 239000013536 elastomeric material Substances 0.000 claims description 4
- 239000012781 shape memory material Substances 0.000 claims description 3
- 239000007943 implant Substances 0.000 description 57
- 210000001367 artery Anatomy 0.000 description 26
- 210000003462 vein Anatomy 0.000 description 26
- 230000010102 embolization Effects 0.000 description 22
- 206010002329 Aneurysm Diseases 0.000 description 15
- 238000011068 loading method Methods 0.000 description 12
- 150000002500 ions Chemical class 0.000 description 11
- 230000002792 vascular Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000005012 migration Effects 0.000 description 6
- 238000013508 migration Methods 0.000 description 6
- 229910001000 nickel titanium Inorganic materials 0.000 description 6
- 239000010409 thin film Substances 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 210000003240 portal vein Anatomy 0.000 description 5
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002440 hepatic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003073 embolic effect Effects 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 210000003090 iliac artery Anatomy 0.000 description 3
- 238000002697 interventional radiology Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 201000004822 varicocele Diseases 0.000 description 3
- 208000036829 Device dislocation Diseases 0.000 description 2
- 206010018852 Haematoma Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000013161 embolization procedure Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002710 gonadal effect Effects 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 210000002563 splenic artery Anatomy 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000001750 Endoleak Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 208000030633 Pulmonary arteriovenous malformation Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- HBCZDZWFGVSUDJ-UHFFFAOYSA-N chromium tantalum Chemical compound [Cr].[Ta] HBCZDZWFGVSUDJ-UHFFFAOYSA-N 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001692 polycarbonate urethane Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000002796 renal vein Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 239000003229 sclerosing agent Substances 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
- 201000002282 venous insufficiency Diseases 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12177—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00982—General structural features
- A61B2017/00995—General structural features having a thin film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12095—Threaded connection
Abstract
There is provided herein an embolisation device, comprising a detachment mechanism on a proximal end. The device comprises a proximal segment and a distal segment. Each of the proximal and distal segments including a stem and a plurality of anchoring bristles extending outwardly and circumferentially from the stem. The device also includes a flow restricting membrane extending from the stem and having a radial extent less than the radial extent of the plurality of anchoring bristles of the proximal segment. The flow restricting membrane does not overlap with the detachment mechanism when the flow restricting membrane is collapsed proximally. lly from the stem. The device also includes a flow restricting membrane extending from the stem and having a radial extent less than the radial extent of the plurality of anchoring bristles of the proximal segment. The flow restricting membrane does not overlap with the detachment mechanism when the flow restricting membrane is collapsed proximally.
Description
AN EMBOLISATION DEVICE RELATED APPLICATIONS The t application is a divisional application of New Zealand patent application no. , which is a divisional application of New Zealand application no. 746276, which is a divisional application of New Zealand application no. 729857, which is a national phase entry of PCT application no. , which claims priority from the EP application nos. 14184807.7, 15151922.0 and 15175292.0, the contents of each of which are incorporated herein by nce.
INTRODUCTION This invention relates to an embolisation device.
Migration of conventional embolisation coils occurs 4-14% of transcatheter embolisations [1,2].
Non-target embolisation is an outcome of coils ion, the impact of which s on the final location of the coils. In the venous system, the consequences can be catastrophic with literature indicating that coils can migrate into the renal vein, right atrium of the heart, lung (pulmonary artery). Percutaneous retrieval of the coils is technically very challenging and frequently cannot be attempted as the coils are often entrapped within the organs and tissue.
Coil migration occurs for various reasons: • Technical error: release of a coil or coil pack too distal or proximal to an adjoining larger vessel or plexus [3,4] • High blood flow areas can cause the coil to migrate.
• Coil: vessel mismatch. The coils are undersized, hence will not injure the vessel wall, will not induce thrombosis, and are likely to migrate. Or the coils are oversized and will act like a guide-wire and pass further distally into the vessel [5,6].
• Vessel dilation: coil migration can occur due to a disparity in the size of coils and dilated vessels, which can change in their ers depending on vessel hemodynamics [7].
• Coils impart a very low radial (anchor) force on the lumen, once a clot forms within the coil, blood flow can force it to migrate.
The profile of the embolisation device and ry system is a al success factor in successfully ing target embolisation locations e.g. the iliac arteries are frequently tortuous 18508422_1 (GHMatters) P42741NZ03 in the presence of nal aortic aneurysms [5]. To combat this issue today, microcatheters are often employed in difficult or tortuous anatomy where use of rd catheters may induce spasm and lead to a failed embolisation procedure [5]. Additionally different stages in a procedure may require catheters with different mechanical properties e.g. ing a visceral vessel, particularly in the presence of diseased or tortuous arteries, may require a catheter with a high degree of stiffness and torque control. In general, the lower the e of the device and delivery system, the greater the accessibility of the device into tortuous and higher order vessels. A lower profile device reduces the diameter of catheter required for delivery and lowers the risks of access site infections, hematomas and lumen spasm.
Dependent on the clinical application of the device, variable anchor forces may be ed to t migration of the prosthesis e.g. arterial and venous applications have variable blood flow rates and . This in turn, will lead to a compromise in terms of profile since in order to anchor the device stiffer, and consequently larger elements may be required. For e in the case of a bristle device larger diameter fibres may be required.
The technique generally used to embolise s today is to insert a metallic scaffold (coil, plug) into the target , to cause a thrombus that adheres to the scaffold, relying on the thrombus to induce blood ion and eventually occlude the . In general, available embolisation technology does not interfere with or interact with blood flow densely enough across the vessel cross section to induce rapid, permanent vessel occlusion.
Using technology available today, the physician will often have to prolong a specific duration of time for the technology to induce occlusion. In one approach the physician inserts coils and then waits 20 minutes for the coils to expand and cause vessel occlusion [8].
The restoration of the lumen of a blood vessel following thrombotic occlusion by restoration of the channel or by the formation of new channels, is termed recanalisation. Recanalisation can occur due to, coil migration, fragmentation of the embolisation material, and formation of a new vessel lumen that circumvents the occlusion [6]. Recanalization rates vary by procedure and embolic agent, g from 10% in portal vein embolisation to 15% for pulmonary arteriovenous malformations to 30% for splenic artery embolisation [9,10,11]. 18508422_1 ters) P42741NZ03 SUMMARY An aspect of the present invention provides an embolisation device, comprising: a detachment mechanism on a proximal end; a proximal segment; a distal t, each of the proximal and distal ts including a stem, and a plurality of anchoring bristles extending outwardly and circumferentially from the stem; and a flow restricting membrane ing from the stem and having a radial extent less than the radial extent of the plurality of anchoring bristles of the proximal segment, wherein the flow cting membrane does not overlap with the detachment mechanism when the flow restricting membrane is sed proximally.
According to ments, in a contracted delivery configuration the bristles of the proximal segment extend partially in a first longitudinal direction and the es of the distal segment extend partially in a second longitudinal direction which is opposite to the first longitudinal direction.
According to embodiments, in a constrained configuration, the membrane has a longitudinal extent. Optionally, in a deployed configuration, the membrane has a conical or cup-like shape.
According to ments, the flow restricting membrane is of a flexible material, optionally wherein the flow restricting ne is of a polymeric material, an elastomeric material or a shape memory material such as Nitinol.
According to embodiments, the flow restricting membrane is located longitudinally within the es of the proximal segment and/or the flow restricting membrane is located longitudinally within the bristles of the distal segment.
According to embodiments, the flow restrictor is not attached to the plurality of es.
According to embodiments, the flow restrictor is more flexible than bristles nt to it.
According to embodiments, a diameter of the bristles in the distal segment is greater than a diameter of the bristles in the proximal segment. 18508422_1 (GHMatters) P42741NZ03 According to ments, the device further comprises a connector n nt segments, optionally wherein a proximal connection between the proximal segment and a segment adjacent to the proximal segment is relatively stiff.
According to embodiments, the stem of the proximal segment is mounted to the stem of the distal segment, optionally wherein the stem of the al t is substantially rigidly mounted to the stem of the distal segment.
According to embodiments, the device further ses a least one of the following: - a distal radiopaque marker which is d on a distal side adjacent to a most distal segment; - a proximal radiopaque marker which is located on a proximal side adjacent to a most proximal marker; and - a radiopaque marker intermediate the proximal segment and the distal segments.
According to embodiments, the stem of the proximal segment and the stem of the distal segment form parts of a continuous stem.
According to embodiments, the device further comprises one or more further segments between the distal segment and the proximal segment. ally, the connections between at least some of the further segments comprise a hinge to facilitate relative movement n the segments.
Optionally, the connection between some of the segments intermediate the proximal segment and the distal segment is relatively rigid.
According to embodiments, the detachment mechanism comprises a stem portion, optionally wherein the stem n is coupled to the stem of the proximal segment. O ptionally, the stem portion is hingedly mounted to the stem of the proximal segment.
According to embodiments, the stem portion has a mounting feature for engagement with a mounting feature of a delivery element. O ptionally, the mounting feature of the stem n comprises a screw thread. 18508422_1 (GHMatters) P42741NZ03 There is further described herein an embolization device, comprising: a proximal segment; a distal segment, each of the proximal and distal segments including a stem, and a plurality of anchoring bristles extending outwardly from the stem, wherein the distal segments includes more bristles than the proximal segment; and a flow restricting membrane.
There is r bed herein an embolization device, comprising: a proximal segment; a distal segment, each of the proximal and distal segments including a stem, and a plurality of anchoring bristles extending outwardly from the stem; and a flow restricting membrane located on the proximal segment.
There is further described herein an embolization device, comprising: a proximal segment; a distal t, each of the proximal and distal ts including a stem, and a ity of anchoring bristles extending outwardly from the stem; and a flow cting membrane located longitudinally within the bristles of one of said segments.
There is further bed herein an embolization device, comprising: a proximal t; a distal t, each of the proximal and distal segments including a stem, and a plurality of anchoring bristles extending outwardly and circumferentially from the stem; and a flow restricting membrane extending from the stem and having an outer dimension less than an outer ion of the plurality of anchoring bristles of the proximal t.
There is further described herein an embolization system, comprising: a delivery catheter; and an embolization device having a loaded configuration when the device is loaded in the ry catheter, and a delivered configuration when the device is urged out from the catheter, the embolization device r including a proximal segment; a distal segment, each of the proximal and distal segments including a stem, and a plurality of anchoring bristles extending outwardly from the stem, the bristles of the proximal segment being deflected in a first direction in the loaded configuration, and the bristles of the distal segment being deflected in a second direction in the loaded uration, the first direction being opposite the second direction; and a flow restricting membrane deflected in the first direction in the loaded configuration.
There is further described herein an embolisation device for promoting clot formation in a lumen comprising at least two segments, each segment comprising a stem and a plurality of flexible 18508422_1 (GHMatters) P42741NZ03 es extending outwardly from the stem, the bristles having a cted delivery configuration and a deployed configuration in which the bristles extend generally radially outwardly from the stem to anchor the device in a lumen n, in the deployed configuration bristles of one segment extend partially in a first longitudinal direction and the bristles of another segment extend partially in a second longitudinal direction which is opposite to the first longitudinal direction.
In one embodiment in the cted delivery configuration the bristles of one segment extend partially in a first longitudinal direction and the bristles of another segment extend partially in a second longitudinal direction which is opposite to the first longitudinal direction.
In one case the device includes a flow restrictor having a contracted delivery configuration and an expanded ed configuration. The flow restrictor may be located adjacent to a proximal end of the device. The flow restrictor may be d within or nt to the most proximal segment.
Alternatively or additionally the flow restrictor is located adjacent to the distal end of the device.
The flow restrictor may be located within or adjacent to the most distal segment.
In one ment the flow ctor comprises a membrane.
In one case a flow restricting membrane is located longitudinally within the bristles of the proximal segment and/or the distal segment. The flow restricting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer dimension of the plurality of anchoring bristles. The flow restricting membrane may be connected to the stem. In some cases the flow restricting membrane may have a central hole. The central hole in the membrane is preferably smaller than the stem on which it is d. The central hole in the ne may have a diameter which is smaller than the diameter of the stem.
The l hole may adapt its shape and dimension at least in part to the shape and dimensions of a cross section of the stem. The central hole may be stretched during mounting in order to fit the stem.
In one case there is an interference fit between the central hole and the stem. 18508422_1 (GHMatters) P42741NZ03 In one case the bristles in an unconstrained configuration extend to a radial extent which is greater than the radial extent of the ne in the unconstrained uration. In the constrained configuration, the membrane may have a longitudinal extent. In the deployed configuration, the membrane may have a l or cup-like shape.
In one ment the flow restrictor is of a flexible material. The flow ctor may be of a polymeric material. The flow restrictor may be of an elastomeric material. The flow restrictor may comprise a film.
In one embodiment the flow restrictor comprises a shape memory material such as Nitinol.
In one case the device comprises connectors between the segments. A proximal connection n the most proximal segment and the segment adjacent to the proximal segment may be relatively stiff. The proximal connection may incorporate or comprise a marker band.
In one embodiment the embolization device comprises only a single proximal segment and a single distal segment. The proximal segment and the distal segment in one case are mounted on a single common stem.
In one embodiment the stem of the proximal segment and the stem of the distal segment form parts of the same continuous stem.
In one embodiment the device comprises a distal marker which is d on the distal side nt to the most distal segment.
In one case the device comprises a proximal marker which is located on the proximal side adjacent to the most proximal marker.
In one ment the device comprises at least one further segment between a distal segment and a proximal segment. There may be a plurality of further t between a distal segment and a proximal segment. The connections between at least some of the further segments may comprise hinges to facilitate relative movement between the further segments. 18508422_1 (GHMatters) P42741NZ03 In one embodiment a proximal end of the device is adapted for releasable connection with a delivery means such as a delivery wire or tube. There may be a connector for connection to the delivery wire. The connector may be ly moveable relative to the most proximal segment.
There is further described herein an embolisation device for promoting clot formation in a lumen comprising at least two segments, each segment sing a stem and a ity of flexible bristles extending outwardly from the stem, the bristles having a contracted delivery configuration and a deployed configuration in which the bristles extend lly radially outwardly from the stem to anchor the device in a lumen, wherein the device includes a flow restrictor having a contracted delivery configuration and an expanded rained configuration.
In one case the flow restrictor is located adjacent to a proximal end of the device. The flow restrictor may be located within or adjacent to the most proximal segment. Alternatively or additionally the flow restrictor is located adjacent to the distal end of the device. The flow restrictor may be located within or adjacent to the most distal segment.
In one embodiment the flow restrictor comprises a membrane. The bristles in an unconstrained configuration may extend to a radial extent which is greater than the radial extent of the membrane in the unconstrained configuration. In the constrained configuration, the membrane may have a longitudinal extent. In the deployed configuration, the membrane may have a conical or cup-like shape.
In one case the flow restrictor may be of a flexible material. The flow restrictor may be of a polymeric material. The flow restrictor may be of an meric al.
In one embodiment the flow restrictor comprises a film. The flow ctor may comprise a shape memory al such as Nitinol.
There is r bed herein an embolisation device for promoting clot formation in a lumen comprising at least two segments, each segment comprising a stem and a plurality of flexible es extending outwardly from the stem, the bristles having a contracted ry configuration and a deployed configuration in which the bristles extend generally radially outwardly from the stem to anchor the device in a lumen, comprising a proximal bristle segment and at least one distal 18508422_1 (GHMatters) P42741NZ03 bristle t, a proximal marker proximal the most proximal segment, a distal marker distal of the most distal t and an ediate marker between the most proximal segment and the segment which is adjacent to the most proximal segment.
There is further described herein an embolisation device for promoting clot formation in a lumen comprising at least two segments, each segment comprising a stem and a plurality of flexible bristles which extend radially outwardly of the stem, the bristles having a contracted delivery configuration and a deployed uration in which the es extend generally radially outwardly of the stem, the bristles comprising distal bristles in a distal bristle segment and proximal bristles in a proximal segment and wherein there are differences between at least some of the distal bristles and at least some of the proximal bristles.
In one case the device comprises at least one intermediate t between the proximal segment and the distal segment, the ediate segment comprising intermediate bristles and wherein there are differences between the intermediate bristles and either or both of the proximal bristles and the distal bristles.
In one ment the differences comprise a difference in radial extent.
At least some of the bristles in the proximal segment may be tapered proximally or distally.
Alternatively or additionally, at least some of the bristles in the distal segment are d ally or distally. Alternatively or additionally, the device comprises at least one intermediate segment and at least some of the bristles in the intermediate section are tapered proximally or directly.
In some embodiments at least some adjacent bristle segments are longitudinally spaced-apart.
In one case the differences comprise differences in ties such as flexibility.
The number of distal bristles may be different from the number of proximal bristles.
In some embodiments at least some of the bristle segments are of non-circular profile in the deployed uration. 18508422_1 (GHMatters) P42741NZ03 There is further described herein an embolization device of the invention and a delivery er.
In one case the delivery catheter is a microcatheter.
There is further described herein an embolisation system comprising:- an embolisation device having a plurality of bristle segments having a contracted ry configuration and an expanded deployed uration; a connector at a proximal end of the embolisation ; and a delivery element which is releasable connected to the connector for ry of the embolisation device into the expanded deployed configuration.
The connector may be configured to facilitate movement between the delivery element and the embolisation device. The connector may be hingedly mounted to the embolisation .
In one case the system further comprises a delivery catheter in which the embolisation device is retained in the retracted configuration.
There is r described herein an zation device comprising: a proximal segment; a distal segment; and a flow restricting member, each of the al and distal segments including a stem and a plurality of anchoring bristles extending outwardly from the stem.
The flow restrictor may comprise a membrane. The flow restricting membrane may be located on the proximal segment. The flow restricting membrane may be located on the distal segment.
In one case a flow restricting membrane is located longitudinally within the bristles of the proximal segment and/or the distal segment. The flow restricting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer dimension of the plurality of ing bristles. The flow restricting membrane may be connected to the stem. In some cases the flow cting membrane may have a central hole. The central hole in the membrane is preferably smaller than the stem on which it is mounted. The central hole in the membrane may have a diameter which is smaller than the er of the stem. 18508422_1 (GHMatters) P42741NZ03 In one case the central hole adapts its shape and dimension at least in part to the shape and dimensions of a cross section of the stem. The central hole may be stretched during mounting in order to fit the stem.
In one case there is an erence fit between the central hole and the stem.
In one case the flow restricting membrane is not attached to the ity of bristles.
The flow restricting ne may be substantially impermeable.
The flow restricting membrane may have a contracted delivery configuration and an expanded deployed configuration. In the constrained configuration, the flow restricting membrane may have a longitudinal extent. In the deployed configuration the flow restricting membrane may have a conical or cup-like shape.
The flow restrictor may be of a flexible material. The flow restrictor may be of a polymeric material. The flow restrictor may be of an elastomeric material. The flow ctor may comprise a film.
In one case the flow restricting membrane is more flexible than the es adjacent to it.
In one ment the distal segment includes more bristles than the proximal segment.
The diameter of the bristles in the distal segment may be greater than the diameter of the bristles in the al segment.
In one case the stem of the proximal segment is mounted to the stem of the distal segment. The stem of the al segment may be substantially rigidly mounted to the stem of the distal segment.
The embolization device in some cases further comprises at least one radiopaque marker. There may be a aque marker adjacent to a distal segment and/or a radiopaque marker adjacent to the proximal segment and/or a radiopaque marker intermediate the proximal and distal segments. 18508422_1 (GHMatters) P42741NZ03 In one ment the device comprises a al tor for releasable connection to a ry element. The proximal connector may comprise a stem portion. The connector stem may be coupled to the proximal segment stem. The connector stem may be hingedly mounted to the proximal segment stem. The connector stem may have a ng feature for engagement with a mounting feature of a ry element. The connector mounting feature may comprise a screw thread.
In one embodiment the zation device comprises only a single proximal t and a single distal t. The proximal segment and the distal segment in one case are mounted on a single common stem.
In one embodiment the stem of the proximal segment and the stem of the distal segment form parts of the same continuous stem.
The embolization device may comprise at least one further segment between the distal segment and the proximal segment. There may be a plurality of further segment between a distal segment and a proximal segment. The connections between at least some of the further segments may comprise a hinge to facilitate relative movement between the further segments. The connection between some of the segments intermediate the proximal segment and the distal segment may be relatively rigid.
In one case the proximal segment comprises from 40 to 150 bristles, in one case 60 to 150, optionally 70 to 110, optionally about 90, in another case 50 to 110, optionally 70 to 90, optionally about 80, in another case 40 to 100, optionally 40 to 75, optionally 40 to 60.
In one case the distal segment comprises from 40 to 180 bristles, in one case 70 to 180, optionally 100 to 150, optionally about 125, in another case 50 to 130, optionally 80 to 100, ally about 90, in another case 40 to 80, optionally 40 to 60.
There is further described herein a method for manufacturing an embolization device comprising the steps of:- 18508422_1 (GHMatters) P42741NZ03 providing a bristle t having a plurality of bristles extending outwardly of the stem; providing a bristle manipulating tool; manipulating at least some of the bristles so that the bristles are aligned with the stem; mounting a flow restrictor membrane between the es; and releasing the bristles from the lating tool.
The method may comprise the step of mounting the membrane on the stem of the bristle segment.
In one case the membrane comprises a central hole which is smaller than the diameter of the bristle stem and the method comprises engaging the stem in the hole of the membrane.
In one case the central hole adapts its shape and ion at least in part to the shape and dimensions of a cross section of the stem. The central hole may be stretched during mounting in order to fit the stem.
In one case there is an interference fit between the central hole and the stem.
BRIEF DESCRIPTION OF THE DRAWINGS The invention will be more clearly understood from the following ption of an embodiment thereof, given by way of example only, with nce to the accompanying drawings, in which: Fig. 1 is a side view of two connected segments of an embolisation device, in an unconstrained state, according to the invention; Fig. 2 is an oblique view of proximal segment of the device of Fig. 1; Fig. 3 illustrates the collapsed configuration of two segments in a catheter, one pointing distally and the other proximally; Fig. 4 shows the deployed configuration of a device with a proximally pointing proximal segment, a membrane, and a ly pointing distal t; 18508422_1 (GHMatters) P42741NZ03 Fig. 5 is a schematic of the flow direction (closed arrows) entering a membrane in the deployed configuration and its effect which facilitates the seal t the vessel wall; Fig. 6 shows the configuration of two distally pointing segments (proximal and distal segments) in the collapsed state; Fig. 7 shows the configuration of two ly pointing segments (proximal and distal segments) in the deployed state; Fig. 8 illustrates an le device, with poor co-linearity with the vessel centre line which may allow flow to pass h; Fig. 9 shows the dimensions of the device in the undeployed state (a) and the vessel diameter definition (b); Fig. 10 illustrates a device with two bristle segments pointing in opposing directions on the same stem; Fig. 11 illustrates a device with two bristle segments in opposing directions, sharing the same stem and without a gap in between; Fig. 12 (a) to (c) illustrates a marking system and the location of markers during different stages of delivery and deployment; Fig. 13 (a) and (b) shows a connection comprising a thread mechanism utilising a d wire stem as a natural male thread - in this schematic a formed hypotube is used as the female thread; Fig. 14 shows a connection sing a thread mechanism in which a hypotube is attached to a delivery wire and detachable from the twisted wire mechanism by a thread mechanism on the hypotube; 18508422_1 (GHMatters) P42741NZ03 Figs. 15 (a) rates an embolisation device in a fully expanded unrestrained configuration and (b) in a ed configuration; Fig. 15 (c) is an exploded view of an embolization device; Figs. 16 (a) and (b) are views similar to Fig. 15 of another embolisation device; Figs. 17 (a) and (b) are views similar to Fig. 15 of a further embolisation ; Figs. 18 (a) and (b) are views similar to Fig. 15 of a still further embolisation device; Fig. 19 is a view of a device of the invention in a packaged configuration ready for use; Fig. 20 is an enlarged view of a loading tube of Fig. 19; Fig. 20 (a) is an enlarged view of a distal end of r loading tube; Fig. 21 is an isometric view of an sation device according to the invention; Fig. 22 is an elevational view of an embolisation device of the invention; Fig. 23 is an isometric view of the device of Fig. 22; Figs. 24 (a) to (d) illustrate the delivery and deployment of the device of Figs. 22 and 23; Fig. 25 is an isometric view of a further embolisation device according to the invention; Figs. 26 (a) and (b) illustrate configurations of another embolisation device; Fig. 27 is an elevational view of portion of a further embolisation device; Figs. 28 (a) to (c) illustrate the deployment of an embolisation device; 18508422_1 (GHMatters) P42741NZ03 Fig. 29 is an enlarged view of portion of an sation device in a deployed configuration; Fig. 30 a to r illustrates a range of geometries for embolisation devices according to the invention; Figs. 31 illustrate an sation device with a low profile; Figs. 32 illustrate another embolisation device according to the invention; Figs. 33 illustrate another embolisation device ing to the invention; Fig. 34 illustrates a further embolisation device including a flow blocking member; Fig. 35 illustrates further embolisation devices according to the invention; Fig. 36 is a diagram of a two t embolization device bridging an aneurysm; Fig. 37 is a diagram of a multi segment embolization device bridging a large aneurysm; and Fig. 38 is a diagram of an embolization device; DETAILED DESCRIPTION Referring to the drawings there is illustrated an embolisation device 1 ing to the invention which comprises a plurality of flexible bristles having deployed and contracted configurations.
The device comprises a series of segments n at least one segment 3 points distally and one t 4 points proximally. In some cases there is only a proximal segment 4 and distal segment The es of the proximal segment 4 point proximally and the bristles of the distal segment 3 point distally. 18508422_1 (GHMatters) P42741NZ03 A proximally pointing segment is defined as a segment in which the bristles point proximally and the membrane (if present) cone is open at the proximal end. A distally pointing segment is defined as a segment in which the bristles point distally and the ne (if present) cone is open at the distal end.
At least one segment in this case the proximal segment 3, incorporates a flow ctor which in this case is a thin film flexible membrane 5.
In some cases a series of radiopaque markers divides the proximally pointing segment 4 and the distally pointing t 3. There may be a proximal marker 6, a distal marker 7 and an intermediate marker 8.
In one case the embolization device comprises only a single proximal segment 4 and a single distal segment 3. The proximal segment 4 and the distal t 3 in one case are mounted on a single common stem. The stem of the proximal segment 4 and the stem of the distal segment 3 may form parts of the same continuous stem.
In the case where the device comprises more than two segments, the connection between the two most proximal segments is more stiff than the distal connections. The distal connections generally comprise a hinge.
In one embodiment, a le ne 5 is present in at least one of the ts. The membrane 5 may comprise a disc of thin film material. The flexibility of the membrane 5 means its orientation is controlled by the orientation of the adjacent bristles – i.e. if the adjacent bristles are forced to point distally the membrane 5 will adjust its configuration accordingly. Thus, if the membrane 5 is deployed from a sed ion, such as from within a catheter, the bristles will cause it to open up to an expanded configuration. The membrane 5 may also be placed proximal or distal to the segment.
In one case, the implant device comprises at least two ts. In one configuration the membrane 5 is in the most proximal segment. This is shown, in an unconstrained state schematically in Figs. 1, 2, 21, 22 and 23. In the configuration shown the membrane 5 is located 18508422_1 (GHMatters) P42741NZ03 within the proximal segment 4 with bristles both proximal and distal to the membrane 5. In some cases there may be a distal membrane 5’.
In one case a flow restricting ne is d longitudinally within the bristles of the proximal segment and/or the distal t. The flow restricting membrane may extend from the stem.
The flow restricting membrane may have an outer dimension which is less than an outer dimension of the plurality of anchoring bristles. The flow restricting membrane may be connected to the stem. In some cases the flow restricting membrane may have a central hole that is an interference fit on the stem. The central hole in the membrane is preferably smaller than the stem on which it is mounted. The central hole in the membrane may have a diameter which is smaller than the diameter of the stem.
The implant has a collapsed configuration to facilitate delivery through a catheter. By placing the membrane 5 within the segment 4, i.e. with bristles proximal and distal to it, it is protected from damage while the implant is being collapsed, or pushed h a catheter. Furthermore, any friction between the catheter and the membrane 5 is reduced.
In one configuration, the implant is collapsed such that, the bristles of the most al segment 4 point ally, while the bristles of the distal segment 3 or segments point distally. Since the membrane orientation is controlled by the orientation of the bristles, if the ne 5 is within the al segment, it will also point proximally. This is shown schematically in Fig. 3.
Fig. 3 shows a collapsed configuration of two segments 3,4 in a catheter 10, one pointing distally and the other proximally. It will be noted that the outer periphery of the membrane 5, shown in the proximal segment 4, is pointing proximally.
When deployed from this configuration, into a vessel a similar but lly expanded configuration to the collapsed configuration is achieved. This means that the bristles of the proximal segment 4 point proximally, and the es of the distal segment 3 point distally. This is shown tically in Fig. 4. In this configuration the implant will be anchored from moving in either direction. This is because the ends of the bristle act in a brake-like fashion increasing friction between the implant and the wall. On the contrary, if all bristles point distally, the force 18508422_1 (GHMatters) P42741NZ03 ed to push the t distally will be greater than that required to push the implant proximally. Thus a device migration may be more likely to occur in the proximal direction.
In one embodiment the membrane 5, when measured in the unconstrained configuration, has a diameter which is less than that of the bristle t, but greater than that of the vessel for which the device is intended. Thus the membrane is sufficiently large in diameter to contact the ference of the vessel. A larger membrane would increase the profile of the implant when in the sed condition necessitating a larger catheter for delivery.
As illustrated in Fig. 4 when the device is deployed into a vessel, with a r diameter than the implant, the membrane 5 assumes a conical or cup-like shape - the open end of the cone proximal to the closed end. In one configuration the deployed t comprises a membrane 5 with a conical shape, the open end of the cone proximal to the distal end. In arteries blood from the heart towards the distal arterial tree, that is from proximal to distal. The configuration ensures that the blood flows into the cone’s volume, i.e. the opening of the cone opposes flow. Thus the blood will act to expand the cone further enhancing the seal between the membrane and the vessel wall (Fig. 5). In this way ion will be facilitated. Thus the greater the force (pressure) of the flow into the cone, the greater the improvement of the seal against the vessel wall.
Fig. 5 shows a tic of the flow direction (closed arrows) entering a membrane 5 in the deployed configuration and its effect on the seal against the vessel wall.
In another embodiment the implant may be collapsed such that all segments point ly. Fig s. 6 and 7 show the configuration of two distally pointing segments 3,4 (proximal and distal segments) in the sed state. When deployed, both the proximal and distal segments will point distally. Similarly, all segments may be collapsed such that all point proximally. This may be advantageous when attempting to occlude a lumen in which flow is from distal to proximal, such as a healthy vein. Figs. 6 and 7 show the configuration of two distally ng segments (proximal and distal segments) in the collapsed and deployed state.
A different degree of under sizing of the ne with respect the segment diameter may be preferable for devices intended for arteries and veins. For example veins are known to distend more than arteries during manoeuvres such as Valsalva. Typically arteries distend by 5 to 15% while veins can distend 20-60%. 18508422_1 (GHMatters) P42741NZ03 To ensure an adequate seal between the membrane 5 and the vessel wall it is preferable that the segment line is co-linear with that of the vessel. Use of at least two segments in the device pointing in opposite directions helps to remedy this problem, i.e. the bristles of the al segment ng proximally, and the es of the distal segment pointing distally. This facilitates a m seal of the cone against the vessel wall about its circumference. As can be seen in Fig. 8, if the segment is not co-linear with the vessel, the membrane may be unstable. This instability may enable flow to open or alter the ne geometry from a cone-like shape (for example by flipping the direction of the cone). Fig. 8 illustrates an unstable device, with poor co- linearity with the vessel centre line which may allow flow to pass through.
The device may e features to e co-linearity of the device with the vessel centreline.
In one embodiment, the diameter of the segment is significantly larger than that of the target .
This improves the stability of the device within the vessel facilitating co-linearity of the segment and the vessel centreline. Thus the implant is significantly oversized compared to the target vessel.
Preferable dimensions are outlined in Table 1 and Table 2 for devices deliverable through 0.0385 to 0.041 inch (0.9779mm to 1.0414mm) and 0.056-0.056 inch (1.4224-1.4224mm) inner diameter catheters respectively. The dimensions are shown schematically in Fig. 9. Fig. 9 shows the dimensions of the device in the undeployed state (a) and the vessel diameter definition (b).
The oversizing (calculated as the percentage difference in diameter between segment diameter and the vessel diameter) is preferably at least 20%, more preferably 50% of the vessel er and more preferably at least 100% of the vessel diameter in which the device is implanted. For example for a target vessel which is 6 mm in diameter, the device er may be at least 7.6mm, ably at least 9mm, more preferably at least 12mm.
To ensure co-linearity in veins, the degree of zing may be increased compared to that used in arteries. This is because veins are known to distend significantly (for example during Valsalva).
In one configuration the minimum over-sizing is 100%.
In one configuration the connection between two segments has some flexibility to enable tracking through tortuous anatomy or to accommodate vessel movement during waking etc. It is preferable that the flexibility of this connection is limited so as to ensure good co-linearity of the segment 18508422_1 (GHMatters) P42741NZ03 with the membrane and the vessel ensuring good vessel occlusion. This prevents the device from deploying in a buckled configuration as it exits the catheter tip.
In one embodiment, the bristle segments are on the same stem 20 and there is a gap 23 between the segments 21, 22 as illustrated in Fig. 10. In another embodiment, two segments 24, 25 on two different stems may be connected. In one configuration this connection comprises a crimped or welded hypotube. Fig. 10 shows a device with two bristles segments 21, 22 pointing in opposing directions on the same stem 20.
In yet another embodiment, the same segment may be ured in the collapsed and deployed configuration so as to have some bristles (and the membrane) pointing ally and some bristles ng distally (Fig. 11). Fig. 11 shows a device with two bristle segments 24, 25 in opposing directions, g the same stem and without a gap in between.
In some instances the physician may wish to deploy at least a n of the device and reposition it if he or she is not ied.
In one case the device incorporates at least one proximally pointing proximal segment, and at least one distally pointing distal segment. If the physician deploys the device completely and then wishes to ve and redeploy the device, the action of retrieving the implant by advancing the guide catheter over it will cause the direction of the proximal t or segments to flip upon passing h the catheter tip. Thus if the implant is loyed all segments will point distally.
This will cause the membrane to be open distally. Thus flow may be able to flow past the outside of the membrane. It may be preferable to avoid this situation.
To mitigate this, a radiopaque marking system may be ed to alert the physician of whether the proximally pointing segment or segments have been deployed from the catheter. Thus the physician can deploy the distally pointing segments, and assess their position without deploying the proximally ng segment or segments. If the physician is unhappy with the position of the distally pointing segments, they may resheath and redeploy them without ng the direction of the proximally pointing segments. 18508422_1 (GHMatters) P42741NZ03 In one configuration a radiopaque marker, distal marker 7, is present at the most distal point of the most distal segment. A second marker, medial marker 8, is present between the distally pointing segment(s) and ally pointing segment(s). A third marker, al marker 6, is present at the most proximal point of the proximally facing segment. In this configuration the section between the distal and medial marker 7,8 defines the distally facing segments which may be deployed, ved/repositioned without any effect on their pointing direction, and the section between the medial and third proximal 6,8 defines the proximally facing segment which should not be deployed until the physician is happy with position of the device.
The deployment of the device using this marking system is shown schematically in Figs. 12(a) to (c) which show the marking system and their locations during different stages of delivery and deployment.
In one case, a section of tube of a radiopaque material known as a marker band may be crimped onto the connection between the segments. In the case in which a hypotube is used to connect the ts, the marker may be placed on one or both of the stems of the segments before the hypotube is crimped in place. In another ment the marker band may be placed onto the hypotube tion. In yet another embodiment the radiopaque marker band may be used to connect two adjacent segments. ment may be facilitated by crimping or welding, soldering, use of an adhesive or other means. In another configuration a marker band may be placed on the stem distal or proximal to the connection between the two ts.
In one embodiment the membrane is made from a thin film of PTFE. In one embodiment the membrane is made from a thin film elastomer such as polyurethane. In one case the membrane is of a plastic polyurethane, such as a poly-ether urethane, for e an aromatic polyether urethane. In one embodiment the membrane incorporates a small hole at its centre. To facilitate placement of the membrane on the bristle segment, the adjacent bristles are collapsed by some means. The membrane can then be threaded over the collapsed bristles into the d position.
Manipulating the membrane over the collapsed bristles into position may require that the hole is stretched to a larger diameter. The use of an elastomer which can odate larger deformations without ently deforming facilitates this step in manufacture facilitates this.
The ability of this material to stretch facilitates placement of the membrane within the t during manufacture. 18508422_1 (GHMatters) P42741NZ03 Because a material such as polyurethane is less lubricious than others ng that the membrane is adequately held against the bristles of the t in the collapsed uration and cannot be pulled off during loading and delivery through a catheter.
In one embodiment the membrane is made from thin film Nitinol. In this instance the bristles are not required to collapse, expand and support the membrane.
Preferably the membrane has a low stiffness. This ensures that its behaviour is ted by the bristles by the adjacent bristles, and that it can easily flex to ensure a good seal at the vessel wall.
Furthermore a stiff membrane may have channels longitudinally. Another problem with a stiff membrane is that cannot fold and conform to a low profile when in the collapsed configuration.
Considering the situation where a polymer membrane such as polyurethane is used, the stiffness of the membrane may be reduced by reducing its thickness to that of thin film. Dimensions for the membrane are outlined in Table 1 and Table 2. The membrane may also be of PTFE, PET, or Nylon. PTFE is particularly suitable as it will enhance lubricity ng the device to be delivered through the catheter without high force.
It is preferable that the device profile when in the collapsed configuration is as low as possible in order to enable delivery through a small bore catheter. This reduces complications such as hematoma and infection at the site of luminal access for the ers. It is also able that the implant be detachable from the delivery wire at the discretion of the physician.
In one configuration, the implant has a detachment mechanism on its proximal end. This ensures that the physician can st its position until he or she is happy, remove the device, or detach the implant at will. For some designs the diameter of the detachment mechanism may exceed that of the stem, or even fill the majority of the space within catheter or sheath used to deliver the implant to the target vessel. Accordingly, when in the collapsed state, if the bristles or membrane overlap the detachment mechanism an sed or excessive profile may occur.
Another solution to this problem is to use a low profile detachment mechanism. In one embodiment, a twisted wire stem may be used wherein the geometry of the twisted wire lly provides a male screw thread as shown in Fig. 13 A female screw thread may then be ed 18508422_1 (GHMatters) P42741NZ03 onto this male screw thread. In one embodiment the female screw thread mechanism comprises a formed hypotube in which the s on the inside of the hypotube intended to mate with the threads of the twisted wire stem are formed in place. Preferably the pitch of the twisted wire brush is the pitch of the thread. A relatively low number of threads may be used with success. A minimum of two female threads is used preferably.
Fig. 13 shows a thread mechanism utilising the twisted wire stem 30 as a natural male thread. In this schematic a formed be 31 is used as the female .
In another embodiment the female screw thread is machined or tapped onto the inside of a tube.
In another configuration the female screw thread ses a coil with a pitch to match that of the male thread ing a reliable screw detachment ism.
In one embodiment the male screw thread 30 is a section of the twisted wire stem of the most proximal segment. In a further embodiment, the female thread or be 31 is attached at its proximal end to a delivery wire 35. This facilitates delivery and detachment of the bustle segment through a catheter. This is illustrated schematically in Fig. 14 which shows a thread mechanism in which a hypotube 31 is attached to a delivery wire 35 and detachable from the twisted wire stem by a thread mechanism. A thread mechanism which does not utilise the twisted wire stem may also be utilised.
Referring in particular to Figs. 22 and 23 in one case a flexible section 40 is provided between the screw detachment mechanism 41 and the most al segment 4 of the implant. In one embodiment this flexible section 40 is a hinge. This flexible n 40 enables delivery and detachment of the implant in tortuous anatomies. This flexible section 40 also serves to ensure that the proximal end of the implant is atraumatic.
In one embodiment the membrane and bristles do not overlap the detachment mechanism. In this case the ment mechanism is located a minimum distance from the most proximal point of the segment such that the bristles and membrane do not, or at least minimally p the detachment mechanism. 18508422_1 (GHMatters) P42741NZ03 A number of potential device urations are shown in Figs. 15 to 18. In Figs. 15(a) and (b) there are two segments – one proximal containing the membrane 4 and one distal. Marker bands 6,7,8 are positioned as described above.
Referring to figs 16(a) and (b) in this case there are additional distal segments 60 and hinge connections 61 are provided between the distal segments to accommodate movement between the segments.
Referring to Figs. 17(a) and (b), in this case the most distal segment also includes a membrane 5’ which has an opening which faces distally in the deployed configuration. A relatively stiff connection 62 is provided between the most distal segment and the nt segment.
Figs. 18(a) and (b) illustrate a device similar to Fig. 17 and again for increased ity when deployed, there is a relatively stiff connection 62 between the most distal segment and the adjacent segment. The connection in this case may be reinforced by or ed by a section of hypotube.
Figs, 19 and 20 show the te device configuration. In the packaged configuration, when ready for use, the implant is stored within a loading tube 50. This loading tube 50 comprises a tube with a haemostasis valve 52 and side arm 51 for flushing. The ry wire 55 is attached to the proximal end of the implant and passes through the haemostasis valve. The implant can be pushed from the loading tube 50 into a catheter for delivery to the target site. In one embodiment the g tube has a taper at its distal end to enable it to easily fit into the luer of the catheter used for delivery of the device to the target vessel.
As previously described the implant is pushed from a loader into a catheter to be pushed to the site of treatment. An example of the loader is shown in Fig. 20. In one ment the loading tube is made from a lubricious al such as PTFE with an outer er of approximately 2.9mm and an inner diameter of approximately 1.65mm. This loading tube is compatible with both 0.056- 0.057" (1.4224mm to 1.4478mm) 5F delivery catheters and 0.035"-0.038" (0.889mm to 0.9652mm) 4Fr ry catheters..
In another embodiment the loading tube has a taper at its distal end to enable it to be compatible with multiple catheters of differing hub geometries used for delivery of the device to the target 18508422_1 (GHMatters) P42741NZ03 vessel. A taper 56 on the loading tube 55 functions by funnelling the bristles 58 of the distal segment of the implant into a conical shape. On exit from the loader, the bristles funnel to a e less than that of the inner diameter of the catheter hub ensuring that the implant can be pushed freely from the loading tube without ng. This allows smooth transition across the tube/catheter interface and within the delivery catheter.
In one preferred embodiment the outer diameter of the loading tube is 2.9mm and the inner diameter is 1.65mm. The distal taper comprises an inner diameter from 0.8mm – 1.3mm tapered over a length of 1 – 6 mm.
Various configurations of ts, membranes and connections are illustrated in Figs. 25 to 29.
In some instances, it may be preferable due to space restrictions within the delivery catheter, to incorporate a different number of bristles within the proximal and distal bristle segment. This enables he number of bristles which encourage thrombus formation and prevent device migration to be sed, while preventing excessive friction within the catheter during delivery and deployment. This is particularly important in the case in which one bristle segment of the t incorporates a membrane since the membrane itself will take up space. It is also able to minimise the diameter of the stem to further enable addition of more bristles. The stem wire preferably has sufficient diameter to ensure that when twisted the bristles are securely held via plastic deformation of the stem wire. The following tables contain preferable combinations of als and dimensions for the implant.
Attribute Materials Range Preferably More Preferably Bristle Any shape memory metal or polymer - Nitinol, Elgiloy, Material Nitinol Stem Wire Stainless Steel, Cobalth Chromium, Cobalt y, L605 or Material Platinum, Tantalum Chromium MP35N Titanium or Nickel Alloy Membrane PTFE, PEEK, Polyurethane, Polyether - Polyether urethane Material urethane, Polyester ne, 80A Polycarbonate urethane Stem Wire - - Annealed Material Condition Table 1 18508422_1 (GHMatters) P42741NZ03 Attribute 0.040in (0.889-1.016mm) ID Catheter Preferably ≥ 0.038in (0.9652mm) Implant for short vessel treatment Range Preferably More Preferably Length of Implant (cm) 1-20 1-6 1.5-2.5 Suitable Artery Diameter (mm) 2-13 3-10 3-7 Suitable Vein Diameter (mm) 2-10 3-8 3-8 Bristle Diameter (in) 0.001-0.002 - 0.00175 (0.0254 - 0.0018 45mm) 0.0508mm) (0.0381- 0.04572mm) Number of ts 2-15 2-15 2 Number of es in Proximal 50-130 70-90 80 Length of Proximal Bristle 2.5-4.0 2.9-3.5 3.5 Segment (mm) Number of es in Distal 60-140 90-110 100 Segment (no. per mm) Length of Distal Bristle Segment 3.0-5.0 3.7-4.5 (mm) 4.4 Membrane Diameter (mm) 6-14 6-10 8 Membrane thickness (µm) < 25 < 18 8-16 Membrane Location Proximal al Proximal segment and distal and distal segment segment Stem Wire Diameter (in) 0.004-0.010 0.005-0.008 0.006 (0.1016- (0.127- (0.1524mm) 0.254mm) 0.2032mm) Distal and Proximal Segment 7-20 10-18 15 Diameter (mm) Gap between segments (mm) 0.5-10 2-5 3-4 Direction of fibres in most Proximally Proximally Proximally pointing proximal segment pointing pointing Direction of fibres in most distal Distally Distally Distally pointing segment, or segments ng pointing Table 2a Attribute Implant for Treatment of Short Vessel Segments 0.054-0.060in (1.3716 – 1.524mm) ID Catheter Preferably 0.056in (1.4224mm) 18508422_1 (GHMatters) P42741NZ03 Range Preferably More Preferably Length of Implant (cm) 1-30 1.5-9 2.0-3.5 Suitable Vein Diameter (mm) 2-14 3-13 5-11 Suitable Artery Diameter 3-10 4-9 5-8 Number of Bristle Segments 1-30 1-25 2 Number of Bristles in Proximal 60-150 70-110 90 Segment Length of Proximal Bristle Segment 2-6 4-5 4.10± 0.5mm Number of Bristles in Distal 70-180 100-150 125 Segment Length of Distal Bristle Segment 2-10 5-7 5.75± 0.5mm Membrane er (mm) 11-20 13-15 14 Membrane thickness (µm) < 25 < 18 810-16 ne Location Proximal and Proximal Proximal segment or distal and distal segment segment Stem Wire Diameter (in) 0.004-0.010 0.005- 0.006 (0.1016- 0.008 (0.1524mm) 0.254mm) (0.127- 0.2032mm) Bristle Diameter (in) 0.001-0.0025 0.00175- 0.002 4- 0.002 (0.0508mm) 0.0635mm) (0.04445- 0.0508mm) Segment Diameter (mm) 14-38 18-30 25 Gap Between Segments 0.5-10 2-5 3-4 Direction of fibres in most proximal ally Proximally Proximally pointing t pointing pointing Direction of fibres in most distal Distally ly Distally pointing segment, or segments pointing ng Table 2b In some instances it may be preferable to use a much longer device for vessel ion. For example, in the case of gonadal veins, devices from 5cm to 15cm, or even 25cm may be required 18508422_1 (GHMatters) P42741NZ03 to treat the entire vessel length. For such a vessel, a lower bristle diameter may be appropriate even in a large vessel (e.g. 10mm diameter) since the increased number of es, due to the increased length and number of segments, means a sufficient anchor force can be achieved. A reduced bristle diameter in combination with a larger number of bristles enables a lower force for advancement through a catheter, and deployment from a catheter. The following table es some able combinations. ute 0.054-0.060in (1.3716-1.524mm) ID er Preferably 0.056in 4mm) Range Preferably More Preferably Length of Implant (cm) 1-30 1.5-9 2.0-3.5 Suitable Vein Diameter (mm) 2-14 3-13 3-12 Number of Bristle ts 2-30 4-25 2 Number of Bristles in Proximal 60-150 70-110 90 Segment Length of Proximal Bristle Segment 2-6 4-5 4.5 Number of Bristles in Distal 70-180 100-150 125 Segment Length of Distal Bristle Segment 2-10 5-7 6.2 Membrane Diameter (mm) 11-20 13-15 14 Membrane thickness (µm) < 25 < 18 8-16 Membrane Location Proximal Proximal and Proximal segment and distal distal t segment Stem Wire Diameter (in) 0.004- 0.005-0.008 0.006 0.010 (0.0127- 4mm) (0.1016- mm) 0.254mm) Bristle Diameter (in) 0.001- 0.00175- 0.002 0.0025 0.002 (0.0508mm) (0.0254- (0.04445- 0.0635mm) 0.0508mm) Segment Diameter (mm) 14-38 18-30 25 Gap Between Segments 0.5-10 2-5 3-4 Direction of fibres in most proximal Proximally Proximally Proximally segment pointing pointing pointing Direction of fibres in most distal Distally Distally Distally pointing segment, or segments pointing pointing Table 3a Attribute 0.054-0.060in (1.3716-1.524mm) ID Catheter Preferably 0.056in (1.4224mm) Implant for long vessel segment treatment 22_1 (GHMatters) P42741NZ03 Range ably More Preferably Length of Implant (cm) 2-30 4-25 10-20 Suitable Vessel Diameter (mm) 2-20 3-15 3-12 Number of Bristle Segments 2-30 4-25 9-22, or approximately 1 segment per cm of implant length Number of Bristles in Proximal 50-110 70-90 80 Segment Length of Proximal Bristle 2-6 2.8-4.2 3.5 Segment (mm) Number of Bristles in Distal 50-130 80-100 90 Length of Distal Bristle 2.5-5 3.5-4.5 3.9 Segment (mm) Membrane Location Proximal and al and Proximal distal segment distal segment segment Membrane Diameter (mm) 11-20 13-15 14 Membrane Thickness (µm) < 25 < 18 9-15 Stem Wire Diameter (in) 0.004-0.010 0.005-0.008 0.006-0.008 (0.1016- (0.127- (0.1524- 0.254mm) mm) 0.2032mm) Bristle Diameter (in) 0.001-0.002 - 0.0175 (0.0254- (0.4445mm) 0.0508mm) Segment Diameter (mm) 14-38 18-30 25 Gap Between Segments (mm) 0.5-10 2-5 3-7 Direction of fibres in most Proximally ally Proximally proximal segment ng pointing pointing ion of fibres in most Distally pointing Distally Distally distal segment, or segments pointing pointing Table 3b Attribute Implant for long vessel segment treatment 0.054-0.060in (1.3716-1.524mm) ID Catheter Preferably 0.056in (1.4224mm) Range ably More Preferably Length of t (cm) 2-30 4-25 5-20 Suitable Vein Diameter (mm) 2-15 3-15 3-112 Suitable Artery Diameter 2-15 4-9 5-7 18508422_1 (GHMatters) P42741NZ03 Number of e Segments 2-30 4-25 9-22, or approximately 1 segment per cm of implant length Number of Bristles in Proximal 50-110 70-90 80 Segment Length of Proximal e 2-6 2.8-4.2 3.40 ± 0.5mm Segment (mm) Number of Bristles in Distal 50-130 80-100 90 Segments Length of Distal Bristle 2.5-5 5 3.70± 0.5mm Segment (mm) Membrane Location al and / Proximal and Proximal or distal segment distal segment segment Membrane Diameter (mm) 11-20 13-15 14 Membrane Thickness (µm) < 25 < 18 10-16 Stem Wire Diameter (in) 0.004-0.010 0.005-0.008 0.006-0.008 6- (0.127- (0.1524- 0.254mm) 0.2032mm) mm) Bristle Diameter (in) 0.001-0.002 - 0.0175 (0.0254- (0.4445mm) Segment er (mm) 14-38 18-30 25 Gap Between Proximal 0.5-10 2-7 3-4 Segments (mm) Gap Between Distal Segments 0.5-10 2-7 6-6.5 Direction of fibres in most Proximally Proximally Proximally proximal segment pointing pointing pointing Direction of fibres in most Distally pointing Distally Distally pointing distal segment, or segments pointing Table 3c In some instances, it is not possible to access a target vessel using a standard catheter or sheath (which usually has an inner diameter of 0.035-0.038 inches (0.889mm - 0.9652mm)). For these 18508422_1 (GHMatters) P42741NZ03 instances a range of catheters have been developed known as microcatheters. These catheters exhibit excellent flexibility, and have an outer diameter lly less than 3.3 French. The internal diameter of these catheters ranges from 0.012 to 0.029 inches (0.3048mm to 0.7366mm). Standard internal diameters are 0.021, 0.024 and 0.027 inches (0.5334, 0.6096 and 0.6858mm). For compatibility with such ers devices of the ion with the following attributes are preferred.
Attribute 0.021-0.029in (0.5334-0.7366mm) ID Preferably 0.027in (0.6858mm) Range Preferably More Preferably Suitable Vessel Diameter (mm) 1.0-6.0 - 1.5 e Diameter (in) 0.0005-0.002 0.0007-0.0015 0.001 (0.0127-0.0508mm) (0.01778- (0.0254mm) 0.0381mm) Number of Segments 1-4 1-2 1 Number of Bristles in Segment 100-500 200-450 300-400 Length of Proximal e 2-10 3.5-9 7 Segment (mm) Diameter of Proximal End of 2-12 3-7 3 Segment (mm) Diameter of Distal End of 4-14 4-10 8 Segment (mm) Stem Wire Diameter (in) 0.003-0.010 0.003-0.006 0.004-0.005 (0.0762-0.254mm) 2- (0.1016-0.127mm) 0.1524mm) Stem Diameter (in) 0.005-0.020 0.005-0.015 0.007 (0.127-0.508mm) (0.127- (0.1778mm) 0.381mm) Gap between segments (mm) None, or 1-5 None, or 1-3 Not Applicable Direction of fibres in most Proximally pointing Proximally ally proximal segment pointing ng Direction of fibres in most distal Distally pointing Distally Distally pointing segment, or ts pointing Table 4a Attribute 0.025-0.030 in (0.635-0.762mm) ID Catheter Preferably ≥0.027in 8mm) Implant for short vessel treatment Range Preferably More Preferably Length of Implant (cm) 1.0-2.5 ≤2.0 ≤15 Suitable Artery Diameter 1.5-7 1.5-5 1.5-4.5 Number of Bristle Segments 1-3 - 2 Number of Bristles in al 100-200 115-135 125 Segment 18508422_1 (GHMatters) P42741NZ03 Length of al Bristle 2-5 2.5-3.5 3 Segment (mm) Number of es in Distal 50-120 70-90 80 Segments Length of Distal Bristle 2-5 2.5-3.5 3 Segment (mm) Membrane Location Proximal and Proximal and Proximal distal segment distal segment t Membrane Diameter (mm) 3-8 4-6 5 Membrane Thickness (µm) < 25 < 18 9-15 Stem Wire Diameter (in) 0.002-0.006 0.003-0.004 0.004 (0.0508- (0.0762- (0.1016mm) 0.1524mm) mm) Diameter of e in 0.00075-0.002 - 0.001 al Segment (in) (0.01905- (0.0254mm) 0.508mm) Diameter of Bristle in Distal 0.001-0.002 - 0.0015 Segment (in) (0.0254- (0.0381mm) 0.0508mm) Segment Diameter (mm) 6-20 -12 10 Gap Between Segments (mm) 0.5-4 1-2 1 Table 4b Attribute 0.025-0.030 in (0.635-0.762mm) ID Catheter Preferably 0.027in (0.6858mm) t for short vessel treatment Range Preferably More Preferably Length of Implant (cm) 1.0-2.5 ≤2.0 ≤1.5 Suitable Artery Diameter 1.5-7 1.5-5 1.5-4.5 Number of Bristle Segments 1-3 - 2 Number of Bristles in Proximal 40-100 40-75 40-60 Segment Length of Proximal Bristle 2-5 2.5-3.5 2 ± 0.5mm Segment (mm) Number of Bristles in Distal 40-80 40-60 40-60 Segments Length of Distal Bristle 2-5 2.5-3.5 2± 0.5mm Segment (mm) 18508422_1 (GHMatters) P42741NZ03 Membrane Location Proximal and/or Proximal and Proximal distal t distal segment segment Membrane Diameter (mm) 3-8 4-7 6 Membrane Thickness (µm) < 25 < 18 7-13 Stem Wire Diameter (in) 0.001-0.005 0.002-0.004 0.003 (0.0254- (0.0508- (0.0762mm) 0.127mm) 0.1016mm) Diameter of Bristle in 0.00075-0.002 0.001- 0.0015 0.0015 Proximal Segment (in) (0.01905- 4- (0.0381mm) 0.0508mm) 0.0381mm) Diameter of Bristle in Distal 0.002 0.001-0.0015 0.0015 Segment (in) (0.0254- (0.254- (0.0381mm) 0.0508mm) 0.0381mm) t Diameter (mm) 6-20 -12 10 Gap Between Segments (mm) 0.5-4 1-2 1 Table 4c A range of geometries, orating gaps n ts may be used. In one embodiment a bristle segment of uniform er may be used (Fig. 30 (a)).
A lower profile collapsed configuration can be achieved for delivery through a microcatheter by using a taper in which the proximal diameter of the bristle t is lower than the distal diameter of the bristle segment. This is shown schematically in Fig. 30 (b). This is achievable since the distal bristles do not need to collapse onto any stem distally, while the proximal bristles lie on all es which are present ly.
In order to ensure adequate anchoring of the implant in the vessel to prevent migration, a specific portion of the bristle segment may be designed such that a minimum degree of oversizing with respect to the vessel diameter is incorporated. The degree of taper introduced may be driven by this. In one configuration the lowest diameter of the bristle segment is at least that of the target vessel diameter. For example in Fig. 30 (f), the lower diameter proximal portion of the implant may be at least that of the target vessel, while the larger diameter may be substantially larger than the target vessel. In one embodiment the lower diameter portion of the segment may be 2-4 mm, while the larger diameter portion of the bristle segment may be 4-8 mm. In another embodiment the diameter of the bristle segment may be approximately the same as the target vessel. 18508422_1 (GHMatters) P42741NZ03 In another uration, a double tapered segment may be used (Fig. 30 (c)), or a number of individual tapered segments may be used (Fig. 30 (d)).
The use of a gap can further improve the efficiency (increase in the number of bristles) with which bristles can be placed within a catheter while maintaining a low profile implant in the collapsed condition. More fibres ensures better anchor force and increased interference with blood flow resulting in better thrombogenicity and shorter time to occlusion. Some examples are shown in Fig. 30 (m-r) and (d). Any combination of these features (gaps and tapers) can further increase the effectives of the implant in anchoring within the vessel and causing vessel ion.
Another means to enable a profile iently low to fit through a microcatheter is the use of bristles of differing types i.e. with different properties. For example, as illustrated in Fig. 31 a large number of fibres of a low er may be incorporated in one area of a segment to induce rapid us formation and vessel occlusion. Similarly a lower number of fibres of a higher diameter may be incorporated. In one embodiment a group of fibres of diameter 0.0007 inches (0.01778mm), and a group of fibres of 0.001 inches (0.0254mm) is used. In another instance a group of fibres of 0.0254mm) and 0.0015 inches (0.0381mm) are used.
When the implant is placed into a catheter it is in a collapsed condition. If all bristles of a segment are collapsed such that they all point one direction, the bristles will lie on top of one r. This increases the profile of the segment in the collapsed condition. A longer segment with more es means a larger profile in the collapsed condition. One means to reduce the profile in the collapsed condition is to collapse some of the fibres such that they point ly, and others such that they point proximally. This is shown tically in Fig. 32.
Following deployment the bristle segment may be resheathed. This will force all fibres which original pointed proximally to be flipped such that they point distally. In one ment there is sufficient space within the microcatheter to enable all bristles to enter the microcatheter. In another configuration a most distal portion of the t may not fully enter the microcatheter due to insufficient space for the bristles i.e. the profile is too high when all fibres of the segment point distally. 18508422_1 (GHMatters) P42741NZ03 In yet another embodiment, the amount and configurations of the bristle segment may be tuned such that while not all fibres can enter the catheter, due to insufficient space, the bristles which remain outside the er are d roughly parallel to the catheter centreline and thus do not contact the vessel wall. This ensures that if the ian wishes to remove the implant or alter its position he or she will cause damage or denudation of the vessel wall.
In yet another embodiment, an extendable tion exists between a distal and proximal segment. This will be advantageous particularly where the collapsed e is too large to be resheathed due to proximal segment bristles overlapping the distal segment bristles. As the physician pulls the proximal segment into the catheter and as the distal segment begins to enter the catheter causing resistance the extendable connection will stretch increasing or enabling a gap to emerge between segments. The increase in the gap size can enable the se of more or all of the segments into the catheter. Fig. 35 (a) shows such a configuration with an extendable connection in the unloaded state. Fig. 35 (b) displays the same configuration in the loaded state with the extendable connection elongated. Fig. 35 (c) shows the resheathing step wherein the catheter collapses the proximal t bristles. This action also causes an elongation of the extendable connection alleviating the degree of overlap of the proximal bristles onto the distal bristles. The extendable connection may comprise a spring or elastic element which can return to its original length upon ing. The extendable connection may comprise non-elastic type element.
Another means to reduce the profile of the e segment is to trim the segment such that it has a non-circular cross section. This is shown schematically in Fig. 33. (a) shows a conventional bristle segment which has not been trimmed. Fig. 33 (b) shows a segment which has been trimmed such that there is a lower diameter region. In this way the longer fibres will serve to ensure the implant is well anchored in the , while the shorter fibres will support thrombus formation. Other noncircular geometries such as a square Fig. 33 (c), triangular or others may be used.
In some implants, a membrane or flow blocking member may be orated. A number of configurations are shown schematically in Fig. 34 which deal with the problem of space constraints within a microcatheter. Since the membrane will contribute significantly to the profile of the implant in the sed configuration, it may be advantageous to place the membrane in an area of the t which is generally of low profile in the collapsed configuration. This low profile 18508422_1 (GHMatters) P42741NZ03 area of the segment may be achieved by any of the means bed above (including reduced segment diameter, use of lower diameter bristles, use of tapers and the like).
As described previously, the t may be detached via a screw mechanism. In one embodiment the female or male portion of the detachment mechanism is comprised of a radiopaque material.
This is to facilitate visibility of detachment during use. In yet another embodiment both female and male portions of the screw detachment mechanism are radiopaque enabling the physician to distinctively see the male detach from the female.
In one embodiment a male n of a screw detachment mechanism is ed to the implant, and the female to the delivery wire. In another embodiment the female portion of the screw detachment mechanism is attached to the implant and the male portion to the delivery wire.
A gap between segments as shown in Fig 9(a) can facilitate a low profile during delivery and retrieval. During retrieval, via re-sheathing of the implant into a catheter, the gap facilitates a low profile when the fibres of the proximal segment which may include a membrane are altered from a proximally pointing configuration to a distally pointing direction. In a situation n retrieval of the implant is not a desirable attribute the gap between the ts may be as low as 1 mm. In another embodiment there may be no gap between the distally and proximal segments.
A further embodiment of the device, deliverable through a atheter, is described in Table 5.
The design is similar to that shown in Fig. 24. In one configuration a larger bristle diameter is used in the distal segment than the al segment. This is to ensure m outward radial force from the distal segment g to anchor the device. A lower bristle diameter may be utilised in the proximal segment in order to tate a membrane in the proximal segment while also being rable through a microcatheter.
As discussed previously, the zing of the device diameter compared to the vessel (calculated as the percentage difference in diameter between segment diameter and the vessel diameter) is preferably at least 20%, more preferably 50% of the vessel diameter and more preferably at least 100% of the vessel diameter in which the device is implanted. Even more preferably, 150% oversizing should be employed. 18508422_1 (GHMatters) P42741NZ03 Embolization Procedures Embolization procedures may be undertaken by a range of physicians, primarily entional radiologists, endovascular surgeons, and interventional cardiologists. There are a number of indications for embolization. Frequently performed procedures, and the associated physician are summarised in the table below.
In embolization in l the flow direction is from proximal to the distal (prograde, or away from the heart). This is the natural flow direction in arteries. In healthy veins, the flow direction will generally be the opposite (retrograde, towards the heart). However in general, embolization is performed in patients with reflux meaning flow will also be prograde.
Because the flow will generally be from proximal to distal it is preferable to have a ne on the proximal end of the device open proximally, with the bristles also pointing proximally. This mitigates any potential for flow to pass around the outside of the membrane.
Indication Primary Target Access Site Direction Notes Physician Vessel for of Flow Occlusion ed Endovascular Accessory Radial Prograde The accessory veins are Maturation of n, Veins in Artery draining the venous Dialysis Access Interventional AVF outflow, ore flow Fistulas Radiologist is the opposite of a normal accessory vein.
Catheter tip points in direction of flow during device delivery.
Accessory Venous Prograde The accessory veins are Veins in Outflow draining the venous AVF outflow, therefore flow is the opposite of a normal accessory vein.
Catheter tip points in direction of flow during device ry. 18508422_1 (GHMatters) P42741NZ03 Hemoptysis Interventional Bronchial Femoral / Prograde Catheter tip points in Radiologist Artery Radial direction of flow during Artery device delivery Pre Op Y-90 entional Gastroduode Femoral / Prograde er tip points in (prevent non- Radiologist nal, Gastric, Radial direction of flow during target Cystic Artery device delivery embolization) Artery Varicocele Vascular Gonadal/ Jugular Prograde Refluxing/diseased Surgeon, Ovarian Vein / vessel, so flow is away Interventional Vein Femoral from heart. Catheter tip Radiologist points in direction of flow during device ry. Membrane may be used to control sant to treat collateral vessels.
Liver Interventional Hepatic Femoral/ Prograde Catheter tip points in Metastases Radiologist Artery Radial direction of flow during Artery device delivery Type II Vascular or Femoral/ Prograde Catheter tip points in Endoleaks Surgeon Mesenteric Radial direction of flow during Artery, Artery device ry Internal Iliac Arteries Pelvic Vascular Ovarian Jugular Prograde ing/diseased Congestion n, Vein, Vein/ vessel, so flow is away Syndrome Interventional Internal or Femoral from heart. Catheter tip Radiologist Pudendal points in direction of Vein flow during device delivery. Membrane may be used to control sclerosant to treat collateral vessels.
Hemorrhoids Vascular Internal Iliac Jugular Prograde Refluxing/diseased Surgeon, or Pudendal Vein/ vessel meaning Vein Femoral haemorrhoidal plexus is 18508422_1 (GHMatters) P42741NZ03 entional not draining ly.
Radiologist Flow is away from heart into the plexus. Catheter tip points in direction of flow during device delivery Hemorroidal Femoral/ Prograde Catheter tip points in Arteries Radial direction of flow during Artery device delivery Liver Cancer: Interventional Portal Vein Trans- Prograde Catheter tip points in Promotion of Radiologist hepatic direction of flow during future remnant entry via device delivery hypertrophy contralateral approach Interventional Portal Vein Trans- de Depending on Radiologist hepatic orientation of entry via er/tip, could be ipsilateral retrograde flow. approach Interventional Portal Vein Jugular Prograde Catheter tip points in Radiologist Vein direction of flow during device delivery Aneurysms entional Splenic, Femoral or Prograde Catheter tip points in Radiologist hepatic Radial direction of flow during artery Artery device delivery Haemorrhage Vascular Any artery Radial or Prograde Catheter tip points in Surgeon, Femoral direction of flow during Interventional Artery device delivery Radiologist Treatment of an aneurysm with a membrane at distal and proximal ends Normally blood flows from proximal to distal in the parent , past an aneurysm, with some filling of the aneurysm sac. It may therefore seem intuitive that occlusion of the proximal inflow towards the aneurysm should prevent flow into the sac. However, in some scenarios occlusion of 22_1 (GHMatters) P42741NZ03 the proximal vessel can alter the hemodynamics of the vessels locally, meaning flow can travel from distal to the aneurysm causing r filling and pressurising of the aneurysm sac. In this scenario the physician aims to occlude the parent vessel proximal and distal to the aneurysm. This is known as front-door backdoor treatment of the aneurysm.
In one embodiment the device may be configured such that there is both a proximal and distal membrane on the device, enabling rapid ion of the parent vessel both al and distal to the aneurysm. Accordingly the proximal membrane is configured to be proximal the aneurysm sac, while the distal membrane is distal to the membrane sac. In a preferable configuration the membrane on the proximal e segment is open proximally, and the membrane on the distal segment is open ly.
One arrangement with two bristle segments 100, 101 each containing a membrane 102, 103 is illustrated in Fig. 36. Another arrangement with several additional ts 105 to bridge a larger aneurysm is illustrated in Fig. 37.
Use of a Stiff and Flexible Interconnects Between Distal Segments in Longer Device In some instances the ties of the segments may be such that no flexible connections in required. For short devices flexible connections may not be required. However for longer devices some flexibility may be required. It is able that at least one flexible tion per 5cm of the implant length be present.
In one configuration, a device has many distal bristle segments in which the distal segments are connected via both le and stiff connections. This may be required when flexible connections between all distal segments mean that the pushability of the implant when being delivered through a catheter is compromised due to too much flexibility. This may be the case in particular where very flexible connections incorporating a hinge are used. The replacement of at least one le connection with a stiff or stiffer connection will improve the column stiffness of the implant and hence its pushability. This will reduce the force required to push the implant through the delivery catheter. It may be preferable to place the stiff connections intermittently between the flexible sections to ensure good flexibility along the length while also maintaining good pushability along the length. 22_1 (GHMatters) P42741NZ03 One such device is illustrated in Fig. 38. This device has proximal and distal segment 110, 111 and a plurality of intermediate segments 112. Some of the connections between the segments are hinged 113 and others are relatively stiff 114.
It is preferable that the membrane is within the bristle segment. A bristle lating tool may be used and some of the bristles may be manipulated so that the bristles are aligned with the stem.
A flow restrictor membrane is mounted between the bristles and fter the bristles are released from the tool or vice versa.
When the bristles recover the membrane will be between and protected and secured by bristles both proximally and distally.
To ensure that the membrane is controlled by the adjacent bristles, some bristles should be present both distal and proximal to the membrane. In one confirmation the membrane 130 is placed such that 50% of bristles are proximal to the membrane while 50% are distal to the membrane. To prevent overlap of the membrane onto structures proximal to the segment (such as a detach mechanism, or ry wire), the membrane may be placed more ly within the segment. In one configuration 60% of fibres are proximal to the ne while 40% are distal to the membrane. In another configuration 70% of fibres are proximal to the membrane while 30% are distal to the membrane. In another uration 80% of fibres are proximal to the membrane while 20% are distal to the membrane. ne Hole er and Interference Fit ent of the membrane within the bristle segments ensures that es inhibit the membrane from translating proximally or distally along the segment while in use or when deployed. The security of the membrane may be further improved via an interference fit between a hole in the membrane and of the segment stem. To achieve this, the hole in the membrane should be smaller than the stem of the segment. Once placed onto the stem the mismatch of the er of the stem and the hole in the membrane will cause on between the two surfaces and an interference fit.
To achieve an interference fit the hole in the membrane should be less the stem diameter.
Preferably the hole diameter in the membrane should be at least 0.001in (0.0254mm) less than the 18508422_1 (GHMatters) P42741NZ03 diameter of the stem. More preferably the hole diameter in the membrane should be at least 0.002in (0.508mm) less than the diameter of the stem.
It will be appreciated that if the hole in the membrane is too small, excessive stretching may be required to apply the membrane to the segment causing irrecoverable deformation of the hole such that no interference may be present or a gap could exist between the stem and the hole in the membrane. In this instance some flow may pass h this gap inhibiting the device performance in terms of occlusion. The hole of the membrane should be no more than 40% less than the er of the stem.
Ideally the hole diameter is specified such that the ratio between the initial hole diameter and stretched hole er should be less than the ultimate elongation of the membrane al such that the membrane hole diameter will recover to its lower diameter causing interference fit with the stem.
The device sed may also be used in fields beyond embolization. For e, these embodiments may be particularly useful in the field of contraception wherein the fallopian tubes are occluded. Furthermore the device disclosed may be used in the field of bronchiopulmonary occlusion. For example, in the case where a physician wishes to exclude a portion of the lung by occluding a bronchus. cations and additions can be made to the embodiments of the invention described herein without departing from the scope of the invention. For example, while the embodiments described herein refer to particular features, the invention includes ments having different combinations of features. The invention also includes embodiments that do not include all of the specific features described.
The invention is not limited to the embodiments before described, with reference to the accompanying drawings, which may be varied in construction and detail. 18508422_1 (GHMatters) P42741NZ03 [Link] http://www.terumois.com/products/embolics/AZUR.aspx References 1. Ekeh et al., cations arising from splenic artery embolisation: a review of an 11-year ence. The American Journal of Surgery, 205, 250-254, 2013 2. Ryer et al. 2013, Comparison of outcomes with coils versus vascular plug embolisation of the internal iliac artery for endovascular liac aneurysm . Journal of Vascular Surgery, Volume 56, Issue 5, November 2012, Pages 1239–1245. 3. Beddy et al., ular varicoceles. Clinical Radiology (2005) 60, 1248–1255 4. Beecroft etal., Percutaneous varicocele embolisation. Canadian Urological Association Journal. September 2007, Volume 1, Issue 3 5. Kessel et al., Transcatheter Embolisation and Therapy. Springer ISBN 97884800 0. hed 2010 6. Balian et al. Pelviperineal venous insufficiency and varicose veins of the lower limbs.
Phlebolymphology. 2008; 15(1):17-26. 7. Marsh et al., Coil Protruding into the Common Femoral Vein Following Pelvic Venous Embolisation. Cardiovascular Interventional Radiology (2008) 31:435–438 8. The Technology of Expansion. Terumo Interventional Systems. aded on ry 21, 2013 from http://www.terumois.com/products/embolics/AZUR.aspx 9. Letourneau-Guillon et al., Embolisation of Pulmonary ovenous Malformations with Amplatzer Vascular Plugs: Safety and Midterm Effectiveness. Journal of Vascular and Interventional Radiology, Volume 21, Issue 5, Pages 649-656, May 2010.
. Yoo et al., Preoperative portal vein embolisation using an amplatzer vascular plug.
European Radiology (2009) 19: 1054-1061. 11. Pelage et al. What is Azur Hydrocoil and How Does it Work? Presented at Society of Interventional Radiology, 2011. 18508422_1 (GHMatters) P42741NZ03
Claims (24)
1. An embolisation device, comprising: a detachment mechanism on a al end; 5 a proximal segment; a distal segment, each of the proximal and distal segments ing a stem, and a ity of anchoring bristles extending outwardly and circumferentially from the stem; a flow restricting membrane extending from the stem and having a radial extent less 10 than the radial extent of the plurality of anchoring bristles of the proximal segment, wherein the flow restricting membrane does not overlap with the detachment mechanism when the flow restricting membrane is collapsed proximally.
2. The device as claimed in claim 1, n in a contracted delivery configuration the bristles 15 of the proximal segment extend partially in a first longitudinal direction and the bristles of the distal segment extend partially in a second udinal direction which is opposite to the first longitudinal direction.
3. The device as claimed in claims 1 or 2, wherein, in a constrained configuration, the 20 membrane has a longitudinal extent.
4. The device as claimed in claim 3, wherein, in a ed configuration, the membrane has a conical or cup-like shape. 25
5. The device as claimed in any one of the preceding claims, wherein the flow restricting membrane is of a flexible material.
6. The device as claimed in claim 5, wherein the flow restricting membrane is of a polymeric material, an elastomeric material or a shape memory material such as l.
7. The device as claimed in any one of the preceding claims, n the flow restricting membrane is located udinally within the bristles of the proximal segment and/or the flow restricting membrane is located udinally within the bristles of the distal segment. 18508422_1 (GHMatters) P42741NZ03
8. The device as claimed in any one of the preceding claims, wherein the flow restrictor is not attached to the plurality of bristles. 5
9. The device as claimed in any one of the preceding claims, wherein the flow restrictor is more flexible than bristles adjacent to it.
10. The device as claimed in any one of the preceding claims, wherein a diameter of the es in the distal segment is r than a diameter of the bristles in the proximal t.
11. The device as claimed in any one of the preceding claims, further comprising a connector between adjacent segments.
12. The device as claimed in claim 11, wherein a proximal connection between the proximal 15 segment and a segment adjacent to the al segment is relatively stiff.
13. The device as claimed in any one of the preceding claims, n the stem of the proximal t is d to the stem of the distal segment. 20
14. The device as claimed in claim 13, wherein the stem of the proximal segment is substantially rigidly mounted to the stem of the distal segment.
15. The device as claimed in any one of the preceding claims, r comprising one or more of the following: 25 - a distal aque marker which is located on a distal side adjacent to a most distal segment; - a proximal radiopaque marker which is located on a proximal side adjacent to a most proximal marker; and - a radiopaque marker intermediate the proximal segment and the distal segments.
16. The device as claimed in any one of the preceding claims, wherein the stem of the proximal segment and the stem of the distal segment form parts of a continuous stem. 18508422_1 (GHMatters) P42741NZ03
17. The device as claimed in any one of the preceding claims, comprising one or more further segments between the distal segment and the proximal segment.
18. The device as claimed in claim 17, wherein the connections n at least some of the 5 further segments comprise a hinge to facilitate relative movement between the segments.
19. The device as claimed in claim 17 or claim 18, wherein the connection between some of the segments intermediate the proximal segment and the distal segment is relatively rigid. 10
20. The device as d in any one of the preceding claims, wherein the ment mechanism comprises a stem portion.
21. The device as claimed in claim 20, wherein the stem portion is coupled to the stem of the al segment.
22. The device as claimed in claim 20 or claim 21, wherein the stem portion is hingedly mounted to the stem of the proximal segment.
23. The device as claimed in claim 20, wherein the stem portion has a ng feature for 20 engagement with a mounting feature of a delivery element.
24. The device as claimed in claim 23, wherein the mounting feature of the stem portion comprises a screw . 18508422_1 ters) P42741NZ03 tnun- Ann-a-::tnu $lnnnnnnuxa
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14184807.7 | 2014-09-15 | ||
EP14184807 | 2014-09-15 | ||
EP15151922.0 | 2015-01-21 | ||
EP15151922 | 2015-01-21 | ||
EP15175292 | 2015-07-03 | ||
EP15175292.0 | 2015-07-03 | ||
NZ755781A NZ755781A (en) | 2014-09-15 | 2015-09-15 | An embolisation device |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ763905A NZ763905A (en) | 2022-03-25 |
NZ763905B2 true NZ763905B2 (en) | 2022-06-28 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020257093B2 (en) | An embolisation device | |
US11571218B2 (en) | Embolisation systems | |
NZ763905B2 (en) | An embolisation device | |
NZ763906B2 (en) | An embolisation device | |
NZ763908B2 (en) | An embolisation device | |
NZ763910B2 (en) | An embolisation device | |
WO2022132778A1 (en) | Occluding medical devices and methods of use |